ArticlePoultry science2026
Fermented palm kernel meal modulates gut barrier and inflammatory gene via short-chain fatty acid production in broiler chickens.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated the effects of dietary inclusion of fermented palm kernel meal (FPKM), produced using Limosilactobacillus fermentum BN21, on growth performance, jejunal histomorphology, cecal short-chain fatty acid (SCFA) production, and the expression of genes related to intestinal barrier function and inflammation in broiler chickens. A total of 320-day-old male broilers were randomly allocated to five dietary treatments containing 0, 25, 50, 75, or 100 g/kg FPKM. Each treatment consisted of eight replicate pens with eight birds per pen, and the pen was considered the experimental unit. Experimental diets were fed from day 11 to 35, covering the grower (days 11-21) and finisher (days 22-35) phases. Dietary inclusion of FPKM up to 75 g/kg did not impair growth performance, whereas 100 g/kg FPKM significantly reduced weight gain and increased feed conversion ratio (P< 0.05). The villus height-to-crypt depth (VH:CD) ratio was significantly higher in the 25 and 50 g/kg FPKM groups, although villus height and crypt depth were unchanged. Cecal concentrations of acetate, propionate, butyrate, and total SCFAs increased linearly with FPKM levels (P< 0.05). Supplementation with FPKM also downregulated claudin-1 (CLDN-1) and upregulated zonula occludens-1 (ZO-1) (P< 0.05). Expression of interleukin-18 (IL-18) decreased, whereas interleukin-10 (IL-10) and interleukin-13 (IL-13) were upregulated (P< 0.001). These findings indicate that dietary inclusion of 50 g/kg FPKM fermented by L. fermentum BN21 improves intestinal health by enhancing SCFA production, intestinal morphology, and immune-related gene expression without compromising growth performance in broilers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.